Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Heart failure (HF) and cardiac arrhythmias are major global health issues.
• Defective calcium (Ca²⁺) handling in cardiac myocytes is a key mechanism in HF and arrhythmias.
• Current therapies have limitations, necessitating novel strategies.

Purpose of the Study:

• To review the role of Ca²⁺-handling proteins in heart failure and arrhythmias.
• To examine recent discoveries and challenges in targeting these proteins.
• To highlight therapeutic implications for developing new treatments.

Main Methods:

• Critical assessment of current research on Ca²⁺-handling proteins.
• Examination of paradigm-shifting discoveries and clinical trial outcomes.
• Analysis of protein expression and function in health and disease.

Main Results:

• Ca²⁺ handling defects are central to the pathogenesis of HF and arrhythmias.
• Targeting Ca²⁺-handling proteins presents significant therapeutic potential.
• Understanding protein function is key to developing effective treatments.

Conclusions:

• Improved understanding of Ca²⁺-handling proteins is crucial for novel therapeutics.
• Targeted therapies could fundamentally alter the course of heart failure and arrhythmias.
• Further research is needed to translate discoveries into clinical practice.